查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1666189

全球医疗机器人市场 - 2025 至 2033 年

Global Medical Robotics Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球医疗机器人市场规模达到 159.5 亿美元，预计到 2033 年将达到 613.3 亿美元，2025-2033 年预测期内的复合年增长率为 16.2%。

医疗机器人是指医疗保健领域用于执行、协助或增强医疗程序和医疗保健服务的机器人技术。这些机器人可以是自主的、半自主的或远端控制的，旨在提高广泛医疗应用的精确度、效率、安全性和结果。医疗机器人用于手术、復健、诊断和病人护理，它们通常整合人工智慧（AI）、机器学习、电脑视觉和电信系统等尖端技术。

医疗机器人市场的市场需求正在快速成长，其驱动因素包括慢性病盛行率不断上升以及微创手术需求不断增长等。随着技术的不断进步，医疗保健领域对机器人系统的需求持续上升。例如，2024 年 8 月，强生医疗科技宣布 DePuy Synthes 推出了一款名为 VELYS 主动机器人辅助系统 (VELYS SPINE) 的系统，该系统已获得美国食品药品监督管理局 (FDA) 的 510(k) 批准，旨在用于规划和实施骶椎、胸腰椎和髂颈椎的脊椎融合手术。

市场动态：

驱动因素与约束因素

人工智慧（AI）与机器学习的融合

人工智慧（AI）和机器学习的融合极大地推动了医疗机器人市场的成长，预计将在预测期内推动市场发展。人工智慧和机器学习演算法使机器人系统能够以更高的准确性和一致性执行手术。人工智慧能够分析患者特定资料（例如病史和影像扫描），从而确保针对每个人优化手术程序，减少人为错误的可能性。

例如，2024 年 7 月，美敦力为 Touch Surgery 数位科技生态系统推出了新的直播功能。 Touch Surgery Live Stream 包含 14 种新的 AI 演算法，旨在增强其在术后分析中的数位能力。这些演算法为腹腔镜和机器人辅助手术提供了人工智慧手术见解。

人工智慧可以处理来自感测器、摄影机和诊断工具的即时资料，以监测患者的生命征象和手术进展。此功能使机器人能够预测和适应不可预见的挑战，即时优化程式。例如，美敦力公司的 Mazor X 是一款由人工智慧驱动的机器人脊椎手术系统，它利用机器学习来分析术前影像（如 CT 扫描和 MRI）并规划最佳手术方法。然后，它根据手术期间收集的即时资料调整程序，提高脊椎手术的准确性。

机器人系统成本高

医疗机器人的高成本是严重阻碍市场广泛应用和成长的主要因素之一。虽然这些系统提供了相当多的好处，但前期投资、维护成本和相关费用使得小型医院和医疗保健提供者难以采用它们，特别是在资源匮乏的环境中。

医疗机器人系统，尤其是先进的手术机器人，初始购买价格相当高。这些系统的成本可能高达数百万美元，许多医院，特别是发展中国家或规模较小的医院，难以负担。例如，达文西手术系统是用于微创手术的最知名的机器人系统之一，其成本可能超过 200 万美元，这还不包括年度服务费用。此外，还有训练、维护和软体升级的成本。

除了购买价格外，机器人系统的维护和运作成本也相当大。这些成本包括年度维护合约、校准、培训和软体升级，所有这些都构成了拥有和操作医疗机器人的总费用。例如，Intuitive Surgical da Vinci 系统每年的维护费用高达 10 万至 20 万美元。这还不包括机器人仪器更换的额外费用（每次手术费用为 1,500 至 2,000 美元）。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 按组件截取片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 人工智慧（AI）与机器学习的融合
    • 限制
      • 机器人系统成本高
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：医疗机器人市场（依产品类型）

  • 手术机器人
  • 復健机器人
  • 非侵入性放射外科机器人
  • 机器人手术器械
  • 远端临场机器人
  • 其他的

第 6 章：医疗机器人市场（按组件划分）

  • 硬体
  • 软体
  • 服务
  • 控制系统

第 7 章：医疗机器人市场（按应用）

  • 骨科
  • 神经病学
  • 心臟病学
  • 妇科
  • 一般外科
  • 復健与物理治疗
  • 肿瘤学
  • 其他的

第 8 章：医疗机器人市场（以最终用户划分）

  • 医院
  • 门诊手术中心
  • 復健中心
  • 研究与学术机构
  • 家庭护理设置
  • 其他的

第 9 章：医疗机器人市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Stryker Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT 分析
  • Medtronic plc
  • Zimmer Biomet
  • Smith+Nephew
  • Globus Medical
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Intuitive Surgical
  • Diligent Robotics Inc.
  • Ronovo Surgical

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MD824

The global medical robotics market reached US$ 15.95 billion in 2024 and is expected to reach US$ 61.33 billion by 2033, growing at a CAGR of 16.2% during the forecast period 2025-2033.

Medical robotics refers to robotic technology in healthcare for performing, assisting or enhancing medical procedures and healthcare services. These robots can be autonomous, semi-autonomous or remotely controlled, and they are designed to improve the precision, efficiency, safety and outcomes of a wide range of medical applications. Medical robots are used in surgeries, rehabilitation, diagnostics and patient care, and they often integrate cutting-edge technologies such as artificial intelligence (AI), machine learning, computer vision and telecommunication systems.

The market demand for the medical robotics market is growing rapidly, driven by several factors ranging from the increasing prevalence of chronic diseases to the growing need for minimally invasive surgeries. As advancements in technology continue, the demand for robotic systems in healthcare continues to rise. For instance, in August 2024, Johnson & Johnson MedTech announced that DePuy Synthes launched a system called the VELYS Active Robotic-Assisted System (VELYS SPINE), which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is intended for use in planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar and sacroiliac spine.

Market Dynamics: Drivers & Restraints

Integration of Artificial Intelligence (AI) & Machine Learning

The integration of artificial intelligence (AI) and machine learning is significantly driving the growth of the medical robotics market and is expected to drive the market over the forecast period. AI and machine learning algorithms enable robotic systems to perform surgeries with increased accuracy and consistency. The ability of AI to analyze patient-specific data (e.g., medical history and imaging scans) ensures that the surgical procedure is optimized for each individual, reducing the chances of human error.

For instance, in July 2024, Medtronic launched its new Live Stream function for the Touch Surgery ecosystem of digital technologies. Touch Surgery Live Stream includes 14 new AI algorithms that are designed to enhance its digital capabilities within post-operative analysis. The algorithms deliver AI-powered surgical insights for laparoscopic and robotic-assisted surgery.

AI can process real-time data from sensors, cameras and diagnostic tools to monitor patient vitals and surgical progress. This capability allows the robot to predict and adapt to unforeseen challenges, optimizing the procedure in real time. For instance, Mazor X by Medtronic, an AI-driven robotic spine surgery system, utilizes machine learning to analyze preoperative images (like CT scans and MRIs) and plan the optimal surgical approach. It then adjusts the procedure based on real-time data collected during surgery, improving spinal surgery accuracy.

High Cost of Robotic Systems

The high cost of medical robotics is one of the major factors that significantly hampers the widespread adoption and growth of the market. While these systems offer considerable benefits, the upfront investment, maintenance costs, and associated expenses make them difficult for smaller hospitals and healthcare providers to adopt, especially in low-resource settings.

Medical robotic systems, especially advanced surgical robots, come with a hefty initial purchase price. These systems can cost millions of dollars, making it difficult for many hospitals, particularly those in developing countries or smaller facilities, to afford them. For instance, the da Vinci Surgical System, one of the most well-known robotic systems used for minimally invasive surgeries, can cost over $2 million, not including annual service costs. Additionally, there are costs for training, maintenance, and software upgrades.

In addition to the purchase price, the maintenance and operation costs of robotic systems are substantial. These costs involve annual maintenance contracts, calibration, training, and software upgrades, all of which contribute to the total expense of owning and operating a medical robot. For instance, the Intuitive Surgical da Vinci system requires annual maintenance that can cost up to $100,000 to $200,000 per year. This doesn't include additional costs for robotic instrument replacements (which can cost $1,500 to $2,000 per procedure).

Segment Analysis

The global medical robotics market is segmented based on product type, component, application, end-user and region.

Product Type:

The surgical robots segment is expected to dominate the medical robotics market share

The surgical robots segment is the dominant and fastest-growing segment within the medical robotics market, driven by significant advancements in minimally invasive procedures, precision surgery and robotic-assisted surgeries. This segment includes systems that are designed to assist in a wide range of surgeries, from general surgery to orthopedic, urological, cardiac surgeries and other surgeries. Minimally invasive surgery involves smaller incisions, less blood loss, faster recovery times and reduced risk of infection compared to traditional open surgeries. Surgical robots enable surgeons to perform these complex procedures with greater precision and control, making them a preferred choice.

For instance, in September 2024, THINK Surgical, Inc., received TMINI Miniature Robotic System 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Persona The Personalized Knee System from Zimmer Biomet. "TMINI addresses surgeon demand for ergonomic, wireless, handheld robotic systems and we believe this will accelerate the adoption of robotics in knee procedures, particularly in the outpatient setting.

As the demand for complex surgeries rises, so does the need for robotic assistance. Surgical robots offer enhanced precision, reducing the risk of human error during intricate procedures, which is particularly important in delicate surgeries like neurosurgery, orthopedic and spinal surgery. For instance, according to the National Institute of Health, globally, a staggering 310 million major surgeries are performed each year, around 40 to 50 million in the USA and 20 million in Europe. This rising surgical procedures accelerating the demand for surgical robots for better patient outcomes.

Geographical Analysis

North America is expected to hold a significant position in the medical robotics market share

The use of robotic-assisted surgeries has increased dramatically in North America especially in the United States, further solidifying the region's leadership in the medical robotics market. Robotic surgery is especially popular in areas like urology, orthopedics, cardiothoracic and neurosurgery. For instance, the da Vinci Surgical System is now commonly used for prostate cancer surgeries in the U.S., with roughly three out of four prostate cancer surgeries in the U.S. performed using da Vinci Surgery.

North America leads the world in the research and development of medical robotics, with numerous companies and academic institutions investing heavily in the advancement of robotic technologies. Innovations in areas like robotic-assisted surgery, rehabilitation robotics, and robotic diagnostics have propelled the region's dominance. Companies like Intuitive Surgical, Medtronic, and Johnson & Johnson have heavily invested in robotic surgery platforms. Intuitive Surgical, for instance, spends a significant portion of its annual revenue on R&D to improve its da Vinci surgical robots.

For instance, in March 2024, Intuitive announced that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company's next-generation multiport robotic system. Da Vinci 5 builds on Intuitive's da Vinci Xi's highly functional design, which surgeons and care teams around the world have used in more than 7 million procedures to date.

The rising number of surgical procedures in the region particularly in the United States is driving the demand for surgical robotics. For instance, according to the Centers for Disease Control and Prevention, in the United States, a total number of 51.4 million inpatient surgical procedures are performed, which further boosts the demand for robotics in the region.

Asia-Pacific is growing at the fastest pace in the medical robotics market

The increasing demand for minimally invasive surgeries, where robotic systems can significantly reduce recovery times and improve surgical outcomes. As the APAC population faces chronic conditions such as cancer, cardiovascular disease and musculoskeletal disorders, the demand for robotic surgeries has surged in the region, which focuses on the development of advanced medical robotics.

For instance, in December 2024, Fortis Escorts launched a next-generation surgical robot. A cutting-edge piece of medical technology, the surgical robot helps perform intricate procedures with more control and accuracy. By enabling minimally invasive operations that promise quicker recovery periods, a lower risk of complications, and better overall patient outcomes, this robot marks a substantial development in robotic-assisted surgery.

Additionally, in June 2024, SS Innovations launched SSI Mantra 3, enabling affordable access to the next-generation surgical innovation. It achieved a historic feat in Indian medical science by completing India's maiden human trial in telesurgery. The Mantra 3 is designed to enhance surgical precision, efficiency and patient outcomes. It features 5 slimmer robotic arms and an immersive 3D HD headset that provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control. Additionally, its cost-effective pricing aims to make advanced surgical technologies more accessible to healthcare institutions across India and globally.

Competitive Landscape

The major global players in the medical robotics market include Stryker Corporation, Medtronic plc, Zimmer Biomet, Smith+Nephew, Globus Medical, Becton, Dickinson and Company, Johnson & Johnson, Intuitive Surgical, Diligent Robotics Inc., Ronovo Surgical and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical robotics market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 186 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Component
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Integration of Artificial Intelligence (AI) & Machine Learning
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Robotic Systems
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Medical Robotics Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Surgical Robots*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Rehabilitation Robots
  • 5.4. Non-invasive Radiosurgery Robots
  • 5.5. Robotic Surgical Instruments
  • 5.6. Telepresence Robots
  • 5.7. Others

6. Medical Robotics Market, By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services
  • 6.5. Control Systems

7. Medical Robotics Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Neurology
  • 7.4. Cardiology
  • 7.5. Gynecology
  • 7.6. General Surgery
  • 7.7. Rehabilitation and Physical Therapy
  • 7.8. Oncology
  • 7.9. Others

8. Medical Robotics Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Rehabilitation Centers
  • 8.5. Research and Academic Institutes
  • 8.6. Home Care Settings
  • 8.7. Others

9. Medical Robotics Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic plc
  • 11.3. Zimmer Biomet
  • 11.4. Smith+Nephew
  • 11.5. Globus Medical
  • 11.6. Becton, Dickinson and Company
  • 11.7. Johnson & Johnson
  • 11.8. Intuitive Surgical
  • 11.9. Diligent Robotics Inc.
  • 11.10. Ronovo Surgical

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us